LeadMD is the #1 performance marketing consultancy that leverages best-in-class technology to make your vision actionable and your outcomes measurable. Breaking down the typical siloes of technology and strategy, LeadMD collaborates with clients to increase revenues, align teams and engage ideal customers. We’ve helped more than 3,500 high-growth companies succeed by building revenue engines that scale on top of marketing and sales platforms like Marketo , Adobe, Salesforce.com and dozens of others.

C-Suite On Deck

Andrea Lechner-Becker, Chief Marketing Officer at LeadMD is an experienced Marketing and Sales Executive with a demonstrated history of working in the marketing and advertising industry.

Skilled in Business Process, Marketo, Sales, Customer Relationship Management (C...

Events

Related News

ANTI-PARASITIC DRUG HALTS CORONAVIRUS REPLICATION IN LAB-GROWN CELLS WITHIN 48 HOURS

GEN | April 06, 2020

news image

An anti-parasitic drug that is available around the world stops SARS-CoV-2 coronavirus from replicating in cells within a couple of days, according to findings from in vitro studies by Monash University’s Biomedicine Discovery Institute (BDI), working with the Peter Doherty Institute of Infection and Immunity. BDI research lead Kylie Wagstaff, PhD, said the studies showed that the drug, ivermectin, started to become effective against SARS-CoV-2 in lab-grown cells within just a day. “...

Read More

Pharmacy Market

THE MCQUADE CENTER FOR STRATEGIC RESEARCH AND DEVELOPMENT AND MINDSET PHARMA COLLABORATE TO DEVELOP PSYCHEDELIC MEDICINES

McQuade | January 06, 2022

news image

The McQuade Center for Strategic Research and Development, LLC, a member of the global Otsuka family of pharmaceutical companies, and Mindset Pharma Inc. announce a collaboration that will support the development of psychedelic medicines. MSRD has made a strategic investment to support the discovery and development of novel chemical entity assets of Mindset, a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurol...

Read More

Business Insights, PHARMACY MARKET

OM1 UNVEILS PATENTED, AI-POWERED PLATFORM TO ACCELERATE PERSONALIZED MEDICINE

businesswire | April 17, 2023

news image

OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today launched PhenOM™, its artificial intelligence-powered platform for personalized medicine. Calibrated using OM1’s longitudinal health history datasets, PhenOM uses AI to identify unique digital phenotypes associated with conditions and outcomes and compare patients’ records to them to highlight risks and opportunities. PhenOM powers personalized healthcare insights at ...

Read More

Business Insights

CAN-FITE GRANTED KEY NASH PATENT IN ISRAEL

Can-Fite BioPharma Ltd. | May 17, 2022

news image

Can-Fite BioPharma Ltd. a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced that its patent titled "An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation" has been granted by the Israel Patent Office. This patent has been issued in approximately 40 countries and territories including Japan, South Korea, Hong Kong, Mexico, and in the European Union. It addre...

Read More
news image

ANTI-PARASITIC DRUG HALTS CORONAVIRUS REPLICATION IN LAB-GROWN CELLS WITHIN 48 HOURS

GEN | April 06, 2020

An anti-parasitic drug that is available around the world stops SARS-CoV-2 coronavirus from replicating in cells within a couple of days, according to findings from in vitro studies by Monash University’s Biomedicine Discovery Institute (BDI), working with the Peter Doherty Institute of Infection and Immunity. BDI research lead Kylie Wagstaff, PhD, said the studies showed that the drug, ivermectin, started to become effective against SARS-CoV-2 in lab-grown cells within just a day. “...

Read More
news image

Pharmacy Market

THE MCQUADE CENTER FOR STRATEGIC RESEARCH AND DEVELOPMENT AND MINDSET PHARMA COLLABORATE TO DEVELOP PSYCHEDELIC MEDICINES

McQuade | January 06, 2022

The McQuade Center for Strategic Research and Development, LLC, a member of the global Otsuka family of pharmaceutical companies, and Mindset Pharma Inc. announce a collaboration that will support the development of psychedelic medicines. MSRD has made a strategic investment to support the discovery and development of novel chemical entity assets of Mindset, a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurol...

Read More
news image

Business Insights, PHARMACY MARKET

OM1 UNVEILS PATENTED, AI-POWERED PLATFORM TO ACCELERATE PERSONALIZED MEDICINE

businesswire | April 17, 2023

OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today launched PhenOM™, its artificial intelligence-powered platform for personalized medicine. Calibrated using OM1’s longitudinal health history datasets, PhenOM uses AI to identify unique digital phenotypes associated with conditions and outcomes and compare patients’ records to them to highlight risks and opportunities. PhenOM powers personalized healthcare insights at ...

Read More
news image

Business Insights

CAN-FITE GRANTED KEY NASH PATENT IN ISRAEL

Can-Fite BioPharma Ltd. | May 17, 2022

Can-Fite BioPharma Ltd. a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced that its patent titled "An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation" has been granted by the Israel Patent Office. This patent has been issued in approximately 40 countries and territories including Japan, South Korea, Hong Kong, Mexico, and in the European Union. It addre...

Read More

Resources

resource image

Business Insights, PHARMA TECH

West Pharmaceutical Services

Video

resource image

Business Insights, PHARMACY MARKET

Sales coaching: preparing for the new reality in pharma

Whitepaper

resource image

VIEWS AND ANALYSIS, PHARMACY MARKET

Non-Clinical Testing Considerations: Drugs vs Devices

Whitepaper

resource image

Business Insights, PHARMA TECH

West Pharmaceutical Services

Video

resource image

Business Insights, PHARMACY MARKET

Sales coaching: preparing for the new reality in pharma

Whitepaper

resource image

VIEWS AND ANALYSIS, PHARMACY MARKET

Non-Clinical Testing Considerations: Drugs vs Devices

Whitepaper

Events

C-Suite On Deck

Andrea Lechner-Becker, Chief Marketing Officer at LeadMD is an experienced Marketing and Sales Executive with a demonstrated history of working in the marketing and advertising industry.

Skilled in Business Process, Marketo, Sales, Customer Relationship Management (C...